New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
09:16 EDTHDSN, NVAX, ANGI, DMND, SEAC, RALY, HTZ, BTU, CMTL, GWPHOn The Fly: Pre-market Movers
HIGHER: Angie's List (ANGI), up 7% after shares upgraded at BofA Merrill Lynch... GW Pharmaceuticals (GWPH), up 7.5% after receiving Fast Track designation for Epidiolex... Comtech (CMTL), up 6% after Q3 earnings beat, raised FY14 outlook. LOWER: Hertz (HTZ), down 10% after warning its Q1 results are "likely to be below consensus," disclosing that errors were identified during its preparation of its financial statements and that certain statements must be restated... Rally Software (RALY), down 23% after downgraded at William Blair, Deutsche Bank and Needham following the company's Q1 results... Novavax (NVAX), down 7.5% after filing to sell $100M of common stock... SeaChange (SEAC), down 10% after reporting disappointing earnings, guidance... Diamond Foods (DMND), down 7.5% after reporting lower than expected Q3 results... Hudson Technologies (HDSN), down 6.5% after 6M share spot secondary offering of shares priced at $2.50... Peabody (BTU), down 2% after shares downgraded at Goldman.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
September 29, 2015
16:13 EDTDMNDDiamond Foods reports Q4 adjusted EPS 23c, consensus 21c
Subscribe for More Information
16:06 EDTNVAXNovavax's RSV F vaccine meets safety endpoints in Phase 1 clinical trial
Subscribe for More Information
15:29 EDTDMNDDiamond Foods October 31 straddle priced for 10.7% movement into Q4
Subscribe for More Information
15:27 EDTDMNDDiamond Foods October volatility elevated into Q4 and outlook
Subscribe for More Information
15:15 EDTDMNDNotable companies reporting after market close
Subscribe for More Information
14:39 EDTNVAXNovavax weakness a buying opportunity, says FBR Capital
FBR Capital would be buyers of Novavax on the pullback today on confusion over the level of protection infants gained from maternal immunization with the company's RSV F protein vaccine. The firm believes investor perceptions are misplaced and recommend buying the stock as a core holding in an emerging small- cap portfolio.
11:04 EDTNVAXNovavax price target lowered to $15 after maternal RSV data at Piper Jaffray
After Novavax released top-line Phase II RSV-F vaccine data, Piper Jaffray analyst Edward Tenthoff said he is not sure that this vaccine will have dramatic uptake in pregnant women. He lowered his price target on Novavax to $15 from $17 to account for a reduced RSV maternal immunization forecast, but maintains on Overweight rating on the stock, citing the "blockbuster potential" of the company's RSV vaccine in the elderly.
10:09 EDTDMNDHigh option volume stocks
Subscribe for More Information
08:49 EDTNVAXNovavax vaccine data results fell short, says Piper Jaffray
Subscribe for More Information
07:00 EDTNVAXNovavax reports women vaccinated with RSV F-protein had a rise in anti-F IgG
Subscribe for More Information
06:49 EDTNVAXNovavax awarded $89M grant for RSV F Vaccine Phase 3 clinical trial
Subscribe for More Information
September 28, 2015
17:06 EDTCMTLComtech sees FY16 GAAP EPS $1.34-$1.50, consensus $1.78
Subscribe for More Information
17:03 EDTCMTLComtech reports Q4 EPS 34c, consensus 37c
Subscribe for More Information
14:41 EDTHTZHertz management to meet with MKM Partners
Meeting to be held in Naples, FL on September 30 hosted by MKM Partners.
September 24, 2015
16:14 EDTDMNDOn The Fly: Top stock stories for Thursday
Stock futures were weak in early pre-market trading and the negative bias was cemented when Dow member Caterpillar (CAT) announced restructuring actions, including plans to cut as many as 10,000 jobs, and slashed its revenue guidance for this fiscal year and next. For most of the day the sellers remained in control, pushing the market down more than 1.5% at one point. In the afternoon, though, the buyers came in and began to pick up perceived bargains, paring the market's losses. The averages closed well off their worst levels, but still in the red, ahead of a much-anticipated speech this evening from Fed Chair Janet Yellen. ECONOMIC EVENTS: In the U.S., there were 267,000 initial jobless claims last week, versus expectations for 272,000 first-time claims. Durable goods orders for August declined 2.0%, versus expectations for a drop of 2.3%. When transportation items were removed, the core reading was breakeven, versus expectations for a rise of 0.1%. The Chicago Fed National Activity Index had a reading of -0.41, versus expectations of +0.24. New home sales jumped 5.7% in August to a 552,000 rate, versus expectations for a rise of 1.6% to a 515,000 rate. In Asia, Japan's stock market reopened for the first time since Friday and the Nikkei suffered a nearly 3% decline as it caught up to other global markets. The slide came despite Japanese Prime Minister Shinzo Abe unveiling new economic targets, including a goal for a 20% increase in the target size of the Japanese economy to 600T yen, though he gave no timeframe for achieving this aspiration. Elsewhere, Norway and Taiwan both cut interest rates this morning. The Norges Bank lowered rates by 25 basis points to 0.75%, while Taiwan cut its benchmark by 12.5 basis points to 1.75% in the nation's first lowering of rates since 2009. COMPANY NEWS: Shares of Caterpillar fell $4.40, or 6.27%, to $65.80 after the heavy machinery maker announced plans for job cuts and lowered its revenue guidance for this year and next. Caterpillar said that it would lay off 4,000-5,000 of its employees between now and the end of 2016 and could lay off up to 10,000 employees by 2018. Caterpillar cut its fiscal year 2015 revenue forecast by $1B and said its sees its fiscal year 2016 revenue to be 5% below this year, adding that it expects revenue declines in all three large segments next year. Before the news was announced, research firm Axiom initiated coverage of Caterpillar with a Sell rating and $28 price target, projecting that the company's calendar 2016 earnings will fall well below the Street consensus view. Other mining and agriculture equipment makers were also weaker following the Dow member's announcement, with Joy Global (JOY) falling 1% and Deere (DE) dropping 2.5%. MAJOR MOVERS: Among the notable gainers was STERIS (STE), which advanced $5.05, or 8.02%, to $68.00 after the Federal Trade Commission was denied an injunction to stop the company's proposed merger with Synergy. Also higher was Diamond Foods (DMND), which gained $2.98, or 9.72%, to $33.65 after dealReporter said the company has held talks with strategic suitors as it explores a potential sale. Among the noteworthy losers was Sientra (SIEN), which crashed $10.88, or 52.87%, to $9.70 after a U.K. regulator suspended the CE certificate for all medical devices made by Silimed, the company's contracted manufacturer. Also lower was Caesars (CZR), which fell 6.6% to $7.51 after Bloomberg reported that the company has reached an impasse in talks with certain junior bondholders and creditors involved in the ongoing restructuring of its operating unit. INDEXES: The Dow fell 78.57, or 0.48%, to 16,201.32, the Nasdaq dropped 18.27, or 0.38%, to 4,734.48, and the S&P 500 lost 6.52, or 0.34%, to 1,932.24.
10:13 EDTDMNDHigh option volume stocks
Subscribe for More Information
09:46 EDTDMNDDiamond Foods calls active on report of talks with strategic suitors
Diamond Foods October 32 and 36 calls are active on total call volume of 1,010 contracts (25 puts) on talks with strategic suitors, according to DealReporter. October call option implied volatility is at 59, November is at 44; compared to its 52-week range of 25 to 49. Active call volume suggests traders taking positions for upside price movement.
09:34 EDTDMNDDiamond Foods jumps 8.5% to $33.29 after report of exploring potential sale
09:33 EDTDMNDDiamond Foods in talks with strategic suitors, dealReporter says
Subscribe for More Information
September 23, 2015
12:11 EDTNVAXNovavax to host analyst and investor day
Analyst and Investor day to be held in New York on September 29 at 9 am. Webcast Link
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use